pubmed-article:2966886 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2966886 | lifeskim:mentions | umls-concept:C0034721 | lld:lifeskim |
pubmed-article:2966886 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
pubmed-article:2966886 | lifeskim:mentions | umls-concept:C0021792 | lld:lifeskim |
pubmed-article:2966886 | lifeskim:mentions | umls-concept:C0013030 | lld:lifeskim |
pubmed-article:2966886 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
pubmed-article:2966886 | lifeskim:mentions | umls-concept:C0332120 | lld:lifeskim |
pubmed-article:2966886 | lifeskim:mentions | umls-concept:C0599668 | lld:lifeskim |
pubmed-article:2966886 | pubmed:issue | 20 | lld:pubmed |
pubmed-article:2966886 | pubmed:dateCreated | 1988-6-20 | lld:pubmed |
pubmed-article:2966886 | pubmed:abstractText | The aziridinium ion of ethylcholine (AF64A) is a neurotoxin that has demonstrated selectivity for cholinergic neurons. Unilateral stereotaxic injection of AF64A into the caudate-putamen of rats, resulted in a decrease in dopamine D-2 receptors as evidenced by a decrease in [3H]-sulpiride binding. Dopamine D-1 receptors, labeled with [3H]-SCH 23390, were unchanged. The efficacy of the lesion was demonstrated by the reduction of Na+-dependent high affinity choline uptake sites labeled with [3H]-hemicholinium-3. These data indicate that a population of D-2 receptors are postsynaptic on cholinergic interneurons within the striatum of rat brain. | lld:pubmed |
pubmed-article:2966886 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:language | eng | lld:pubmed |
pubmed-article:2966886 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2966886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2966886 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2966886 | pubmed:issn | 0024-3205 | lld:pubmed |
pubmed-article:2966886 | pubmed:author | pubmed-author:WamsleyJ KJK | lld:pubmed |
pubmed-article:2966886 | pubmed:author | pubmed-author:DawsonT MTM | lld:pubmed |
pubmed-article:2966886 | pubmed:author | pubmed-author:DawsonV LVL | lld:pubmed |
pubmed-article:2966886 | pubmed:author | pubmed-author:FillouxF MFM | lld:pubmed |
pubmed-article:2966886 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2966886 | pubmed:volume | 42 | lld:pubmed |
pubmed-article:2966886 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2966886 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2966886 | pubmed:pagination | 1933-9 | lld:pubmed |
pubmed-article:2966886 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:meshHeading | pubmed-meshheading:2966886-... | lld:pubmed |
pubmed-article:2966886 | pubmed:year | 1988 | lld:pubmed |
pubmed-article:2966886 | pubmed:articleTitle | Evidence for dopamine D-2 receptors on cholinergic interneurons in the rat caudate-putamen. | lld:pubmed |
pubmed-article:2966886 | pubmed:affiliation | Department of Psychiatry, University of Utah Medical Center, Salt Lake City 84132. | lld:pubmed |
pubmed-article:2966886 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2966886 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:2966886 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2966886 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2966886 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2966886 | lld:pubmed |